Uterine Fibroid in Breast Cancer Patients receiving Tamoxifen Therapy
Abstract Objective: Selective estrogen receptor modulators (SERMs) such as tamoxifen play a role in increasing the risk of developing uterine Fibroid. Methods: Case report Case: Mrs. 47 years old, Para 6, presented with chief complaints of vaginal bleeding since a year ago. The patient was diagnose...
Saved in:
Main Authors: | Rismawati Tambunan (Author), Fahriatni (Author), Hasanuddin (Author) |
---|---|
Format: | Book |
Published: |
Indonesian Society of Obstetrics and Gynecology,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mitotically Active Leiomyoma of the Uterus in a Postmenopausal Breast Cancer Patient Receiving Tamoxifen
by: I-Feng Liu, et al.
Published: (2006) -
Ultrasonic, hysteroscopic and histological evaluation of the endometrium in women receiving tamoxifen for breast cancer
by: N. S. Melnikova, et al.
Published: (2014) -
Endometrial ablation for prevention of recurrent endometrial pathology in postmenopausal breast cancer patients receiving tamoxifen
by: I O Mamikonyan, et al.
Published: (2015) -
Features of ultrasound of endometrial pathological conditions in breast cancer patients receiving tamoxifen: a review of literature
by: M. A. Chekalova, et al.
Published: (2020) -
UTERINE FIBROIDS AND WOMEN'S REPRODUCTIVE FUNCTION. COMMUNICATION UTERINE FIBROIDS WITH INFERTILITY
by: V. B. Tskhay, et al.
Published: (2016)